Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing multicenter study of Geli/adalimumab for non-infectious uveitis
CTR20213249Phase 4Active
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Feb 2022
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in noninfectious uveitis (NIU), sponsored by Bio-Thera Solutions, Ltd.. Started Feb 2022; status: active.
02
Drugs
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on CTR20213249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213249.